BIBLIOGRAFIA

AUSTIN, M.A. Triglicerides and coronary artery disease-Metha-Analysis-Atheroesclerosis. 1994; pp: 109-259.
AVIRAM, M. AND I. MAOR. AND A. PHOSPHOLIPASE. Modified LDL is taken Up at Enhanced Rate by Macrophages. Biochemical and Biophysical Research Comunications. 1992; 185:465-472.
BACHORIK, P.S. Lipid and lipoprotein analysis with desk -top analysers. In Rifai N. Wamick G.R. (eds): Laboratory measurement of lipids, Lipoproteins and Apolipoproteins. Washington DC. AACC PRESS. 1994.
BACHORIK, P.S., RIFKI, B.M. AND P.O. KWITEROVICH. Lipids distiporoteinemias clinical diagnosis and Management by Laboratory Methods. 19Th edition, W.B. Saunders Company. Philadelphia. 1996. Pp:642-681.
CASTELLI, W., GARRISON, R.J., WILSON, P.W.F. et al. Incidence of coronary heart disease and lipoprotein cholesterol leves. The Framingham Study. JAMA. 1986; 256:2835-2838.
CLINICAS COLOMBIANAS DE CARDIOLOGIA. I Consenso Nacional sobre Detección, Evaluación y Tratamiento de las Dislipoproteinemias en Adultos. Melgar, Colombia. 1998. 268p.
COLDITZ, G.A., RIMM, E.B., et al. A prospective estudy of parental history of miocardial infarction and coronary artery disease in men. Am. J. Cardiol. 1991; 67:933-938.
DAVIS, C.E., GORDON, D., LAROSA, J. Et al. Correlations of plasma high density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations . The Lipid Research Clinics ProgramPrevalence Study. Circulation. 1980; 62(suppl IV):IV-24 - IV-30.
FONTBONNE, A. AND E. ESCHWEGE. Insulin-resistence hypertriglyceridemia and cardiovascular risk: The Paris Prospective Study. Diabetes Metab. 1001; 17:93-95.
FRIEDEWALD, Wt., LEVY I.R. AND D.S. FREDRICKSON. Estimation of concentration of low-denditylipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Blin. Chem. 1972. 18:499-502.
GENG, Y.J., KODAMA, T. AND G. HAMSSON. Differential Expression of Scanvenger Receptor Isoform During Monocyte-Macrophage Differentiation and foam Cell Formation. Arterioscler. Thromb. 1994; 14:798-806.
GOLDSTEIN, J.L.. AND M.S. BROWN. Lipoprotein Metabolism in the Macrophages Implication for Cholesterol Deposition in Atherosclerosis (Review). Ann. Rev. Biochem. 1983; 52:223-261.
HEINECKE, J.W. Cellular Mechanisms for the Oxidative Modification of Lipoproteins. Implications for Atherogenesis. Coron. Artery Dis. 1994; 5:205-210.
HUBERT H,B. , FEINLEIB, M. et al. Obesity as an independent risk factor for cardiovascular disease: Framingham heart study. Circulation. 1983; 67:968-977.
INTERNATIONAL LIPID INFORMATION BUREAU. Manual ILIB sobre lípidos para práctica Clínica. Waverly Hispánica S.A. Buenos Aires. 1998.
JURGENS, G., CHEN, Q., ESTERBAUER, H., MAIR, S., LEDINSKI, G. AND H.P. DINGES. Immuno StainningHuman Autopsy Aortas with Antibodies to Moddified Apolipoprotein B and Apolipoprotein (a). Arteriocler. Thromb. 1993; 13:1689-1699.
MANNINEN, V., TENKANEN, M., KOSKINEN P., HUTTUNEN, J.K. et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentration on coronary heart disease risk in yhe Helsinki Heart Study.
MARTIN, M.J., HULLEY, S.B., BROWNER, W.S. AND L.H. KULLER. Went.worth D: Serum cholesterol blood pressure and mortality: implications from a cohort of 361.662 men. Lancet. 1986; 2:933-936.
NATIONAL CHOLESTEROL EDUCATION PROGRAM. Detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment Panel II). NIH Publucation No. 93-3095, 1993.
NORDESTGAARD, B., WOOTON, R. AND B. LEWIS. Selective Retention of VLDL, IDL and LDL in yhe Arterial Intima of Genetically Hyperlipidemic rabbits in vivo . Arherosclerosis Vasc. Biol. 1995; 15:534-542.
SMALL, D.M. Progression and Regression of Atherosclerosis Lesion Insights from Lipid Physical Biochemistry. Arteriosclerosis. 1988; 8:103-129. SOLTERO, I. Ateroeclerosis al día IV. Caracas, Venezuela. 2000; 315 p.
SOMA, M.R., BAUTTA, R. AND P. CROSIGNANI. The menopause and lipid Metabolism. Curr. Opinion Lipidol. 1997; 8:229-235.
STEN, J. Et al. Benefits of cholesterol screening and therapy for primary Prevention of cardiovascular disease: a new paradigm. J. Am. Board fam. Pract.. 1988; 11(1):72-77.
VIJAYAGOPAL, P., SRINLVASAN, S.R., RADHAKRISHNAMURTHY, B. AND G.S. BERENSON. Lipoprotein proteoglycan Complexes from Atherosclerosis Lesion Promote Cholesteryl Ester Accimilation in Human Monocytes//Macrofages. Arterioscler.Thromb. 1992; 12:237-249.
VIJAYAGOPAL, P. AND L. GLANCY. Macrofages Stimulate Cholestryl Ester Accumulation Cocultured Smooth Muscle Cells Incubated with LipoproteinProteoglycan Complex. Arterioscler. Thromb. Vasc. Biol. 1996; 16:1112-1121.

Dora Inés Molina de Salazar
Docente Facultad de Ciencias para la Salud Universidad de Caldas
Expresidente SOLAT Colombia (Sociedad Latinoamericana de Ateroesclerosis)
Miembro ILIB-Colombia (International Lipid Information Bureau)
Miembro Junta Directiva Colegio Panamericano del Endotelio
Presidenta Asociación Colombiana de Medicina Interna 2.000 - 2002